Today Sponge Sale To Americans By Internet Pharmacies Investigated By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is looking into online pharmacies' sale of the Today Sponge contraceptive to American consumers despite its lack of approval for sale in the U.S
You may also be interested in...
GSK OTC Boycott Urged In Multi-State “Tums Down” Campaign
Senior advocacy groups in more than 10 states across the country are urging consumers to boycott GlaxoSmithKline's OTC drug products through press events and postcards, e-mails and telephone calls to GSK and congressional leaders
STD, AIDS Risks Despite Today Sponge Use Conveyed In Labeling - NDAC
Proposed labeling for Allendale Pharmaceuticals' Today Sponge contains adequate information regarding Toxic Shock Syndrome (TSS), STDs and AIDS, the Nonprescription Drugs Advisory Committee determined July 12.
Today Sponge Comparative Efficacy Labeling Supported By NDAC
FDA's Nonprescription Drugs Advisory Committee voted in favor of placing comparative efficacy labeling on the outer packaging of Allendale Pharmaceuticals' Today Sponge vaginal contraceptive at a July 12 meeting in Bethesda, Md.